Research Repository

Circulating nucleic acids as biomarkers of prostate cancer

Sita-Lumsden, A and Fletcher, CE and Dart, DA and Brooke, GN and Waxman, J and Bevan, CL (2013) 'Circulating nucleic acids as biomarkers of prostate cancer.' Biomarkers in Medicine, 7 (6). 867 - 877. ISSN 1752-0363

Full text not available from this repository.


Prostate cancer, the most common cancer of western men, requires new biomarkers, especially given that the benefits of PSA testing remain uncertain. Nucleic acids can now be accurately and sensitively detected in human blood. Over the last decade, investigations into utility of circulating cell-free miRNA, DNA and mRNA as novel biomarkers have expanded exponentially. In the near future, they may be routinely used to accurately diagnose cancers, stratify indolent from aggressive disease and inform treatment decisions. However, advancement of such tests into clinical settings is hampered by technical problems with assay specificity and sensitivity, and small study sizes. This review highlights the different forms of circulating nucleic acids and those that show the most potential as viable biomarkers for prostate cancer. © 2013 Future Medicine Ltd.

Item Type: Article
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Science and Health > Life Sciences, School of
Depositing User: Jim Jamieson
Date Deposited: 27 Jan 2014 13:39
Last Modified: 05 Oct 2019 02:15

Actions (login required)

View Item View Item